Stem cells and TCF proteins: A role for β-catenin-independent functions

Stem Cell Reviews

Volumn 3, Issue 1, 2007, Pages 39-48

  Yi, Fei ^a   Merrill, Bradley J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Stem cells; Tcf proteins; Wnt signal

Indexed keywords

BETA CATENIN; T CELL FACTOR 3; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL PROLIFERATION; HUMAN; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN BINDING; SEQUENCE HOMOLOGY; STEM CELL;

AMINO ACID SEQUENCE; ANIMALS; BETA CATENIN; CELL PROLIFERATION; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; STEM CELLS; TCF TRANSCRIPTION FACTORS;

EID: 34748896686     PISSN: 15508943     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12015-007-0003-9     Document Type: Article

References (93)

1. Morrison, S. J., Wandycz, A. M., Akashi, K., Globerson, A., & Weissman I. L. (1996). The aging of hematopoietic stem cells. Natral Medicine, 2, 1011-1016.
2. Rossi, D. J., Bryder, D., Zahn, J. M., Ahlenius, H., Sonu, R., Wagers, A. J., et al. (2005). Cell intrinsic alterations underlie hematopoietic stem, cell aging. Proceedings of the National Academy of Sciences of the United States of America, 102, 9194-9199.
3. Beachy, P. A., Karhadkar, S. S., & Berman, D. M. (2004). Tissue repair and stem cell renewal in carcinogenesis. Nature, 432, 324-331.
4. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 100, 3983-3988.
5. Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Natural Medicines, 3, 730-737.
6. Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., et al. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Research, 63, 5821-5828.
7. Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., et al. (2004). Identification of human brain tumour initiating cells. Nature, 432, 396-401.
8. van Amerongen, R., & Berns, A. (2006). Knockout mouse models to study Wnt signal transduction. Trends in Genetics, 22, 678-689.
9. Arce, L., Yokoyama, N. N., & Waterman, M. L. (2006). Diversity of LEF/TCF action in development and disease. Oncogene, 25, 7492-7504.
10. Clevers, H. (2006). Wnt/β-catenin signaling in development and disease. Cell, 127, 469-480.
11. Kimelman, D., & Xu, W. (2006). The β-catenin destruction complex: Insights and questions from a structural perspective (review). Oncogene, 25, 7482-7491.
12. Mikels, A. J., & Nusse, R. (2006). Wnt as ligands: Processing, secretion and reception. Oncogene, 25, 7461-7468.
13. Takemaru, K. I., & Moon, R. T. (2000). The transcriptional coactivator CBP interacts with beta-catenin to active gene expression. Journal of Cell Biology, 149, 249-254.
14. Hecht, A., Vleminckx, K., Stemmler, M. P., van Roy, F., & Kemler, R. (2000). The p300/CBP acetyltransferases function as transcriptional coactivators of β-catenin in vertebrates. EMBO Journal, 19, 1839-1850.
15. Barker, N., Hurlstone, A., Musisi, H., Miles, A., Bienz, M., & Clevers, H. (2001). The chromatin remodeling factor Brg-1 interacts with β-catenin to promote target gene activation. EMBO Journal, 20, 4935-4943.
16. Kramps, T., Peter, O., Brunner, E., Nellen, D., Froesch, B., Chatterjee, S., et al. (2002). Wnt/Wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell, 109, 47-60.
17. Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., et al. (2003). A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423, 409-414.
18. Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., et al. (2003). Wnt proteins are lipidmodified and can act as stem cell growth factors. Nature, 423, 448-452.
19. Van Mater, D., Kolligs, F. T., Dlugosz, A. A., & Fearon, E. R. (2003). Transient activation of beta-catenin signaling in cutaneous keratinocytes is sufficient to trigger the active growth phase of the hair cycle in mice. Genes & Development, 17, 1219-1224.
20. Gat, U., DasGupta, R., Degenstein, L., & Fuchs, E. (1998). De Novo hair follicles morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin. Cell, 95, 605-614.
21. Blanpain, C., Lowry, W. E., Geoghegan, A., Polak, L., & Fuchs, E. (2004). Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell, 118, 635-648.
22. Lowry, W. E., Blanpain, C., Nowak, J. A., Guasch, G., Lewis, L., & Fuchs, E. (2005). Defining the impact of β-catenin/TCF transactivation on epithelial stem cells. Genes & Development, 19, 1596-1611.
23. van de Watering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I.., Hurlstone, A., et al. (2002). The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell, 111, 241-250.
24. Sansom, O. J., Reed, K. R., Hayes, A. J., Ireland, H., Brinkmann, H., Newton, I. P., et al. (2004). Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes & Development, 18, 1385-1390.
25. Nusse, R., van Ooyen, A., Cox, D., Fung, Y. K., & Varmus, H. (1984). Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature, 307, 131-136.
26. Kinzler, K. W., & Vogelstein B. (1996). Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
27. Morin, P. J. (1999). Beta-catenin signaling and cancer. Bioessays, 21, 1021-1030.
28. Simon, M., Grandage, V. L., Linch, D. C., Khwaja, A. (2005). Constitutive activation of the Wnt/β-catenin signalling pathway in acute myeloid leukemia. Oncogene, 24, 2410-2420.
29. Coluccia, A. M., Vacca, A., Dunach, M., Mologni, L., Redaelli, S., Bustos, V H., et al. (2007). Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. EMBO Journal, 26, 1456-1466.
30. Muller-Tidow, C., Steffen, B., Cauvet, T., Tickenbrock, L., Ji, P., Diederichs, S., et al. (2004). Translocation products in acute myeloid leukemia activate the Wnt signaling in hematopoietic cells. Molecular and Cellular Biology, 24, 2890-2904.
31. Tetsu, O., & McCormick, F. (1999). β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-426.
32. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., et al. (1998). Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
33. Roose, J., Huls, G., van Beest, M., Moerer, P., van der Horn, K., Goldschmeding, R., et al. (1999). Synergy between tumor suppressor APC and the beta-catenin Tcf4 target Tcf1. Science, 285, 1923-1926.
34. Roose, J., & Clevers H., (1999). TCF transcription factors: Molecular switches in carcinogenesis. Biochimica et Biophysica Acta, 1424, M23-37.
35. Maretto, S., Cordenonsi, M., Dupont, S., Braghetta, P., Broccoli, V., Hassan, A. B., et al. (2003). Mapping Wnt/beta-catenin signaling mouse development and in colorectal tumors. Proceedings of the National Academy of Sciences of the United States of America, 100, 3299-3304.
36. Daniels, D. L., & Weis, W. I. (2005). Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nature Structural and Molecular Biology, 12, 364-371.
37. Roose, J., Molenaar, M., Peterson, J., Hurenkamp, J., Brantjes, H., Moerer, P., et al/ (1998). The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature, 395, 608-612.
38. Cavallo, R. A., Cox, R. T/, Moline, M. M., Roose, J., Polevoy, G. A., Clevers, H., et al. (1998). Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature, 395, 604-608.
39. Brantjes, H., Roose, J., van De Wetering, M., & Clevers, H. (2001). All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Research, 29, 1410-1419.
40. Tutter, A. V., Fryer, C. J., & Jones, K. A. (2001). Chromatinspecific regulation of LEF-1 beta-catenin transcription activation and inhibition in vitro. Genes & Development, 15, 3342-3354.
41. Atcha, F. A., Munguia, J. E., Li, T. W., Hovanes, K., & Waterman, M. L., (2003). A new beta-catenin-dependent activation domain in Tcell factor. Journal of Biological Chemistry, 278, 16169-16175.
42. Hovanes, K., Li, T. W., Munguia, J. E., Truong, T, Miliovanovic, T, Lawrence Marsh, J., et al. (2001). Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nature Genetics, 28, 53-57.
43. Li, T. W., Ting, J. H., Yokoyama, N. N., Bernstein, A., van de Wetering, M., & Waterman, M. L. (2006). Wnt activation and alternative promoter regression of LEF 1 in colon cancer. Molecular and Cellular Biology, 26, 5284-5299.
44. Shulewitz, M., Soloviev, I., Wu, T., Koeppen, H., Polakis, P., & Sakanaka C. (2006). Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer. Oncogene, 25(31), 4361-4369.
45. Ivanova, N. B., Dimos, J. T., Schaniel, C., Hackney, J. A., Moore, K. A., & Lemischka, I. R. (2002). A stem cell molecular signature. Science, 298, 601-604.
46. Merrill, B. J., Gat, U., DasGupta, R., & Fuchs, E. (2001). Lef-1 and Tcf-3 transcription factors mediate tissue specific Wnt signaling during Xenopus development. Genes & Development, 15, 1688-1705.
47. Tumbar, T., Guasch, G., Greco, V., Blanpain, C., Lowry, W. E., Rendl, M., et al. (2004). Defining the epithelial stem cell niche in skin. Science, 303, 359-363.
48. DasGupta, R., & Fuchs, E. (1999). Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development, 126, 4557-4568.
49. Kim, C. H., Oda, T., Itoh, M., Jiang, D., Artinger, K. B., Chandrasekharappa, S. C., et al. (2000). Repressor activity of Headless/TCF-3 is essential for vertebrate head formation. Nature, 407, 913-916.
50. Roei, G., Hamilton, F. S., Gent, Y., Bain, A. A., Destree, O., & Hoppler, S. (2002). LEF-1 and Tcf-3 transcription factors mediate tissue-specific Wnt signaling during Xenopus development. Current Biology, 12, 1941-1945.
51. Nguyen, H., Rendl, M., & Fuchs, E. (2006). Tcf-3 governs stem cell features and represses cell fate determination, in skin. Cell, 127, 171-1.83.
52. Rendl, M., Lewis, L., & Fuchs, E. (2005). Molecular dissection of mesenchymal-epithelial interactions in the hair follicle. PLoS Biology, 3, e331.
53. Blanpain, C., & Fuchs, E. (2006). Epidermal stem cells of the skin. Annual Review of Cell and Develpment Biology, 22, 339-373.
54. Chazaud, C., & Rossant, J. (2006). Disruption of early proximodistal patterning and AVE formation in APC mutants. Development, 133, 3379-3387.
55. Perea-Gomez, A., Vella, F. D., Shawlot, W., Oulad-Abdelghani, M., Chazaud, C., Meno, C., et al. (2002). Nodal antagonists in the anterior visceral endoderm prevent the formation of multiple primitive streaks. Developmental Cell, 3, 745-756.
56. Merrill, B. J., Pasolli, H. A., Polak, L., Rendl, M., Garcia-Garcia, M. J., Anderson, K. V., et al. (2004). Tcf3: A transcriptional regulator of axis reduction in the early embryo. Development, 131, 263-274.
57. Popperl, H., Schmidt, C., Wilson, V., Hume, C. R., Dodd, J., Krumlauf, R., et al. (1997). Misexpression of CWntSC in the mouse induces an ectopic embryonic axis and causes a truncation of the anterior neuroectoderm. Development, 124, 2997-3005.
58. Ishikawa, T. O., Tamai, Y., Li, Q., Oshima, M., & Taketo, M. M. (2003). Requirement for tumor suppressor APC in the morphogenesis of anterior and ventral mouse embryo. Developmental Biology, 253, 230-246.
59. Zeng, L., Fagotto, F., Zhang, T., Hsu, W., Vasicek, T. J., Perry 3rd, W. L., et al. (1997). The mouse fused locus encodes axis, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell, 90, 181-192.
60. Pereira, L., Yi, F., & Merrill, B. J. (2006). Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell selfrenewal. Molecular and Cellular Biology, 26, 7479-7491.
61. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., et al, (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell, 113, 643-655.
62. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., et al. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell, 113, 631-642.
63. Ying, Q. L., Nichols, J., Chambers, I., & Smith, A. (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboartion with STAT3. Cell, 115, 281-292.
64. Kuroda, T., Tada, M., Kubota, H., Kimura, H., Hatano, S. Y., Suemori, H., et al. (2005). Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Molecular and Cellular Biology, 25, 2475-2485.
65. Rodda, D. J., Chew, J. L., Lim, L. H., Loh, Y H., Wang, B., Ng, H. H., et al. (2005). Transcriptional regulation of Nanog by OCT4 and SOX4. Journal of Biological Chemistry, 280, 24731-24737.
66. Wu da, Y., & Yao, Z. (2005). Isolation and characterization of the murine Nanog gene promoter. Cell Research, 15, 317-324.
67. Monk, M., & Holding, C. (2001). Human embryonic genes re-expressed in cancer cells. Oncogene, 20, 8085-8091.
68. Hochedlinger, K., Yamada, Y., Beard, C., & Jaenisch, R. (2005). Ectopic expression of OCT4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell, 121, 465-477.
69. Zhang, J., Wang, X., Chen, B., Suo, G., Zhao, Y., Duan, Z., et al. (2005). Expression, of Nanog gene promotes NIH3T3 cell proliferation. Biochemical and Biophysical Research Comunications, 338, 1098-1102.
70. Piestun, D., Kochupurakkal, B. S., Jacob-Hirsch, J., Zeligson, S., Koudritsky, M., Domany, E., et al. (2006). Nanog transformed NIH3T3 cell and targets cell-type restricted genes. Biochemical and Biophysical Research Comunications, 343(1), 279-285.
71. Clark, A. T., Rodriguez, R. T., Bodnar, M. S., Abeyta, M. J., Cedars, M. I., Turek, P. J., et al. (2004). Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. Stem Cells, 22, 169-179.
72. Ezeh, U. I., Turek, P.J., Reijo, R. A., & Clark, A. T. (2005). Human embryonic stem cell, genes OCT4, NANOG, STELLAR, and G.D.F3 are expressed in both seminoma and breast carcinoma. Cancer, 104(104), 2255-2265.
73. Gibbs, C. P., Kukekov, V. G., Reith, J. D., Tchigrinova, O., Susiov, O. N., Scott, E. W., et al. (2005). Stem-like cells in bone sarcomas: Implications for tumorigenesis. Neoplasia, 7, 967-976.
74. Miravet, S., Piedra, J., Miro, F., Itarte, E., Garcia de Herreros, A., & Dunach, M. (2002). The transcriptional factor Tcf4 contains different binding sites for beta-catenin and plakoglobin, Journal of Biological Chemistry, 277, 1884-1891.
75. Vadlamudi, U., Espinoza, H. M., Ganga, M., Martin, D. M., Liu, X., Engelhardt, J. F., et al. (2005). PITX2, beta-catenin and. LEF-1 interact to synergisticaliy regulate the LEF-1 promoter. Journal of Cell Science, 118, 1129-1137.
76. Sheridan, P. L., Sheline, C. T., Cannon, K., Voz, M. L., Pazin, M. J., Kadonaga, J. T., et al. (1995). Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes & Development, 9, 2090-2104.
77. Giese, K., Kingsley, C., Kirshner, J. R., & Grosschedl, R. (1995). Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes & Development, 9, 995-1008.
78. Carlsson, P., Waterman, M. L., & Jones, K. A. (1993). The hLEF/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in. T cells. Genes & Development, 7, 2418-2430.
79. Yasumoto, K., Takeda, K., Saito, H., Watanabe, K., Takahashi, K., & Shibahara, S. (2002). Mkrophthalmia-associated transcription factor interacts with LEF-I, a mediator of Wnt signaling. EMBO Journal, 21, 2703-2714.
80. Bruhn, L., Munnerlyn, A., & Grosschedl, R. (1997). ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCR alpha enhancer function. Genes & Development, 11, 640-653.
81. Ghogomu, S. M., van. Venrooy, S., Ritthaler, M., Wedlich, D., & Gradl, D. (2006). HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription. Journal of Biological Chemistry, 281, 1755-1764.
82. Pukrop, T., Gradl, D., Henningfeld, K. A., Knochel, W., Wedlich, D., & Kuhl, M. (2001). Identification, of two regulatory elements within the high mobility group box transcription factor XTCF-4. Journal of Biological Chemistry, 276, 8968-8978.
83. Nishita, M., Hashimoto, M. K., Ogata, S., Laurent, M. N., Ueno, N., Shibuya, H., et al. (2000). Interaction, between Wnt and TGF-β signalling pathways during formation, of Spemann's organizers. Nature, 403, 781-785.
84. Labbe, E., Letamendia, A., & Attisano, L. (2000). Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways. Proceedings of the National Academy of Sciences of the United States of America, 97, 8358-8363.
85. Boras, K., & Hamel, P. A. (2002). Alx4 binding to LEF-1 regulates N-CAM promoter activity. Journal of Biological Chemistry, 277, 1120-1127.
86. Kahler, R. A., & Westendorf, J. J. (2003). Lymphoid, enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation, of the osteocalcin promoter. Journal of Biological Chemistry, 278, 11937-11944.
87. Valenta, T., Lukas, J., Doubravska, L., Fafilek, B., & Korinek, V. (2006). HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies. EMBO Journal, 25, 2326-2337.
88. Kusano, S., & Raab-Traub, N. (2002). I-mfa domain proteins interact with axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways. Molecular and Cellular Biology, 22, 6393-6405.
89. Prieve, M. G., Guttridge, K. L., Munguia, J., Waterman, M. L. (1998). Differential, importin- recognition and nuclear transport by nuclear localization signals within the high-mobility-group DNA binding domains of lymphoid enhancer factor 1 and T-cell factor 1. Molecular and Cellular Biology, 18, 4819-4832.
90. Beland, M., Pilon, N., Houle, M., Oh, K., Sylvestre, J. R., Prinos, P., et al. (2004). Cdxl autoregulation is governed by a novel Cdx1-LEF1 transcription complex. Molecular and Cellular Biology, 24, 5028-5038.
91. Brannon, M., Brown, J. D., Bates, R., Kimelman, D., & Moon, R. T. (1999). XCtBP is a XTct-3 co-repressor with roles throughout Xenopus development. Development, 126, 3159-3170.
92. Park, J. I., Kim, S. W., Lyons, J. P., Ji, H., Nguyen, T. T., Cho, K., et al. (2005). Kaiso/p120-catenin and TCF/β-catenin complexes coordinately regulate canonical Wnt gene targets. Developmental Cell, 8, 843-854.
93. Hikasa, H., & Sokol, S. Y (2004). The involvement of Frodo in. TCF-dependent signaling and neural tissue development. Development, 131, 4725-4734.